Hyundai Bioscience

048410.KQ

9.96 USD

0.02

+0.20%

Overview

Last close

9.96 usd

Market cap

396.60M usd

52 week high

29.00 usd

52 week low

9.94 usd

Target price

N/A usd

Valuation

P/E

N/A

Forward P/E

N/A

Price/Sales

60.6354

Price/Book Value

11.3114

Enterprise Value

406.63M usd

EV/Revenue

61.8594

EV/EBITDA

-64.6317

Key financials

Revenue TTM

6.57M usd

Gross Profit TTM

2.41M usd

EBITDA TTM

-5.19M usd

Earnings per Share

N/A usd

Dividend

N/A usd

Total assets

105.70B usd

Net debt

N/A usd

About

Hyundai Bioscience Co., Ltd. operates as a biotechnology company. The company provides Vitabrid C12, a vitamin C product that delivers active vitamin C into the skin. It develops Polytaxel, a drug for pancreatic cancer and solid tumors; and CP-COV03 drug for Covid 19. The company was founded in 2000 and is based in Seoul, South Korea.